This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jamieson, W.R. E. Articles by Ling, H. Search for Related Content PubMed Articles by Jamieson, W.R. E. Articles by Ling, H.

(Circulation. 1995;92:101-106.)
© 1995 American Heart Association, Inc.

Articles

Influence of Coronary Artery Bypass and Age on Clinical Performance After Aortic and Mitral Valve Replacement With Biological and Mechanical Prostheses

Presented in part at the 67th Scientific Sessions of the American Heart Association, Dallas, Tex, November 14-17, 1994, and published in abstract form (Circulation. 1994;90[pt 2]).

W.R. Eric Jamieson, MD; A. Ian Munro, MD; Lawrence H. Burr, MD; Eva Germann, MSc; Robert T. Miyagishima, MD; Hilton Ling, MD

From St Paul's Hospital and Vancouver Hospital and Health Science Centre, University of British Columbia, Vancouver, Canada.

Correspondence to Dr W.R. Eric Jamieson, St Paul's Hospital, c/o 910 W 10th Ave, Vancouver, BC V5Z 4E3, Canada.

Abstract The influence of prosthetic type, age, and coronary artery bypass grafting (CABG) on valve-related complications by valve position was evaluated in a population of 2353 bioprosthesis patients (mean age, 66.5 years; range, 13 to 89 years) and in a population of 1112 mechanical prosthesis patients (mean age, 59.1 years; range, 13 to 91 years). The follow-up was complete to 96% and 98%, respectively, for the bioprosthesis and mechanical prosthesis groups. The patient groups were evaluated by actuarial assessment of survival and valve complications and composites. Preoperative factors were evaluated for determination of significant independent predictors by multivariate proportional-hazard regression analysis. CABG was an influential factor in the actuarial analysis. Survival was superior for aortic mechanical replacements without CABG and for mitral replacements, both biological and mechanical, without CABG (P<.05). The freedom from thromboembolism (TE) and antithromboembolic hemorrhage (ATH) was greater for biological prostheses with and without CABG for aortic replacements (P<.05) but not for mitral replacements (P=NS). The freedom from valve-related mortality was not influenced by CABG for either position (P=NS). The freedom from valve-related reoperation was greater for biological prostheses with CABG than without CABG for both aortic and mitral replacements (P<.05). The evaluation of covariates as independent predictors revealed CABG to be a nonpredictor for aortic valve replacement (AVR) (P=NS) but a predictor of survival and valve-related reoperation for mitral valve replacement (MVR) (P<.05). With AVR, biological prostheses predicted greater freedom from valve-related mortality and TE and ATH (P<.05) and for MVR for TE and ATH (P<.05). Valve position was not a predictor otherwise (P=NS). Advancing age was a significant covariate for AVR for all areas of assessment. Advancing age for MVR provided a lower rate of survival and greater freedom from valve-related mortality and reoperation (P<.05). The clinical performance of valvular prostheses is influenced to a greater degree by valve type and age than by CABG.

Key Words: prostheses

This article has been cited by other articles:

				P. M. Davierwala, M. A. Borger, T. E. David, V. Rao, M. Maganti, and T. M. Yau Reoperation is not an independent predictor of mortality during aortic valve surgery J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 329 - 335. [Abstract] [Full Text] [PDF]

				W. E. Jamieson, E. Germann, G. J Fradet, S. V Lichtenstein, R. T Miyagishima, W. E. Jamieson, E. Germann, G. J Fradet, S. V Lichtenstein, and R. T Miyagishima Bioprostheses and Mechanical Prostheses Predictors of Performance Asian Cardiovasc Thorac Ann, June 1, 2000; 8(2): 121 - 126. [Abstract] [Full Text] [PDF]